AbbVie | ABBV - Activos Circulantes

Precio De Mercado
198.71
Cambio Diario
-2.24 -1.11%
Mensual
-4.09%
Anual
6.80%
Q2 Expectativa
194.46




Activos Circulantes Cambio Fecha
AbbVie USD 29.06B 523M 2025-12
Abbott USD 26B 1.16B 2025-12
ALKERMES USD 1.93B 187.5M 2025-12
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Coherus Biosciences USD 206.71M 254.25M 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
J&J USD 59.17B 3.55B 2026-03
Medtronic USD 24.07B 75M 2025-12
Merck USD 47.56B 10.49B 2025-09
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
UCB EUR 6.05B 733M 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
United Therapeutics USD 3.7B 208.5M 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Zoetis USD 6.77B 185M 2025-12